Harvard Bioscience
HBIO
HBIO
95 hedge funds and large institutions have $65.5M invested in Harvard Bioscience in 2024 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 35 increasing their positions, 25 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.58% less ownership
Funds ownership: 71.74% → 71.17% (-0.58%)
22% less capital invested
Capital invested by funds: $84.2M → $65.5M (-$18.7M)
96% less call options, than puts
Call options by funds: $2K | Put options by funds: $51K
Holders
95
Holding in Top 10
1
Calls
$2K
Puts
$51K
Top Buyers
| 1 | +$1.08M | |
| 2 | +$264K | |
| 3 | +$249K | |
| 4 |
AE
AMH Equity
Great Neck,
New York
|
+$234K |
| 5 |
WN
Williams & Novak
Westlake Village,
California
|
+$209K |
Top Sellers
| 1 | -$629K | |
| 2 | -$524K | |
| 3 | -$389K | |
| 4 |
BFM
Boothbay Fund Management
New York
|
-$389K |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$346K |